|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RG, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar
|
|
4
|
Wu S, Wu F and Jiang Z: Identification of
hub genes, key miRNAs and potential molecular mechanisms of
colorectal cancer. Oncol Rep. 38:2043–2050. 2017. View Article : Google Scholar
|
|
5
|
Mourtzikou A, Stamouli M, Kroupis C,
Christodoulou S, Skondra M, Kastania A, Pectasides D, Athanasas G
and Dimas C: Evaluation of carcinoembryonic antigen (CEA),
epidermal growth factor receptor (EGFR), epithelial cell adhesion
molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9)
levels in colorectal cancer patients and correlation with
clinicopathological characteristics. Clin Lab. 58:441–448.
2012.
|
|
6
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
View Article : Google Scholar
|
|
7
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar
|
|
8
|
Takahashi O, Hamada J, Abe M, Hata S,
Asano T, Takahashi Y, Tada M, Miyamoto M, Kondo S and Moriuchi T:
Dysregulated expression of HOX and ParaHOX genes in human
esophageal squamous cell carcinoma. Oncol Rep. 17:753–760.
2007.
|
|
9
|
Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L
and Li SQ: Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1
with the prognosis of esophageal squamous cell carcinoma. Med
Oncol. 29:151–160. 2012. View Article : Google Scholar
|
|
10
|
Gu ZD, Shen LY, Wang H, Chen XM, Li Y,
Ning T and Chen KN: HOXA13 promotes cancer cell growth and predicts
poor survival of patients with esophageal squamous cell carcinoma.
Cancer Res. 69:4969–4973. 2009. View Article : Google Scholar
|
|
11
|
Han Y, Lu S, Wen YG, Yu FD, Zhu XW, Qiu
GQ, Tang HM, Peng ZH and Zhou CZ: Overexpression of HOXA10 promotes
gastric cancer cells proliferation and HOXA10(+)/CD44(+) is
potential prognostic biomarker for gastric cancer. Eur J Cell Biol.
94:642–652. 2015. View Article : Google Scholar
|
|
12
|
Sentani K, Oue N, Naito Y, Sakamoto N,
Anami K, Oo HZ, Uraoka N, Aoyagi K, Sasaki H and Yasui W:
Upregulation of HOXA10 in gastric cancer with the intestinal mucin
phenotype: Reduction during tumor progression and favorable
prognosis. Carcinogenesis. 33:1081–1088. 2012. View Article : Google Scholar
|
|
13
|
He YX, Song XH, Zhao ZY and Zhao H: HOXA13
upregulation in gastric cancer is associated with enhanced cancer
cell invasion and epithelial-to-mesenchymal transition. Eur Rev Med
Pharmacol Sci. 21:258–265. 2017.
|
|
14
|
He X, Liu Z, Xia Y, Xu J, Lv G, Wang L, Ma
T, Jiang L, Mou Y, Jiang X, et al: HOXB7 overexpression promotes
cell proliferation and correlates with poor prognosis in gastric
cancer patients by inducing expression of both AKT and MARKs.
Oncotarget. 8:1247–1261. 2017.
|
|
15
|
Joo MK, Park JJ, Yoo HS, Lee BJ, Chun HJ,
Lee SW and Bak YT: The roles of HOXB7 in promoting migration,
invasion, and anti-apoptosis in gastric cancer. J Gastroenterol
Hepatol. 31:1717–1726. 2016. View Article : Google Scholar
|
|
16
|
Chen SW, Zhang Q, Xu ZF, Wang HP, Shi Y,
Xu F, Zhang WJ, Wang P and Li Y: HOXC6 promotes gastric cancer cell
invasion by upregulating the expression of MMP9. Mol Med Rep.
14:3261–3268. 2016. View Article : Google Scholar
|
|
17
|
Zhang Q, Jin XS, Yang ZY, Wei M, Liu BY
and Gu QL: Upregulated Hoxc6 expression is associated with poor
survival in gastric cancer patients. Neoplasma. 60:439–445. 2013.
View Article : Google Scholar
|
|
18
|
Liao WT, Jiang D, Yuan J, Cui YM, Shi XW,
Chen CM, Bian XW, Deng YJ and Ding YQ: HOXB7 as a prognostic factor
and mediator of colorectal cancer progression. Clin Cancer Res.
17:3569–3578. 2011. View Article : Google Scholar
|
|
19
|
Guo YB, Shao YM, Chen J, Xu SB, Zhang XD,
Wang MR and Liu HY: Effect of overexpression ofHOXgenes on its
invasive tendency in cerebral glioma. Oncol Lett. 11:75–80. 2016.
View Article : Google Scholar
|
|
20
|
Dickson GJ, Liberante FG, Kettyle LM,
O’Hagan KA, Finnegan DP, Bullinger L, Geerts D, McMullin MF, Lappin
TR, Mills KI, et al: HOXA/PBX3 knockdown impairs growth and
sensitizes cytogenetically normal acute myeloid leukemia cells to
chemotherapy. Haematologica. 98:1216–1225. 2013. View Article : Google Scholar
|
|
21
|
Cheng TL and Chang WT: Construction of
simple and efficient DNA vector-based short hairpin RNA expression
systems for specific gene silencing in mammalian cells. Methods Mol
Biol. 408:223–241. 2007. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Fernald K and Kurokawa M: Evading
apoptosis in cancer. Trends Cell Biol. 23:620–633. 2013. View Article : Google Scholar
|
|
24
|
Brentnall M, Rodriguez-Menocal L, De
Guevara RL, Cepero E and Boise LH: caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar
|
|
25
|
Zeren T, Inan S, Vatansever HS and Sayhan
S: Significance of apoptosis related proteins on malignant
transformation of ovarian tumors: A comparison between Bcl-2/Bax
ratio and p53 immunoreactivity. Acta Histochem. 116:1251–1258.
2014. View Article : Google Scholar
|
|
26
|
Samarghandian S, Nezhad MA and Mohammadi
G: Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in
the A549 human lung adenocarcinoma epithelial cells. Anticancer
Agents Med Chem. 14:901–909. 2014. View Article : Google Scholar
|
|
27
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar
|
|
28
|
Mullen P: PARP cleavage as a means of
assessing apoptosis. Methods Mol Med. 88:171–181. 2004.
|
|
29
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: Emt: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar
|
|
30
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar
|
